Clinical and demOgRaphic features of patients with uncontrolled Severe Asthma in Russia (CORSAR)

Trial Identifier: D5180R00037
Sponsor: AstraZeneca
Start Date: January 2024
Primary Completion Date: June 2027
Study Completion Date: June 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Astrakhan, Russia
Russia Barnaul, Russia
Russia Blagoveshchensk, Russia
Russia Bryansk, Russia
Russia Chelyabinsk, Russia
Russia Ekaterinburg, Russia
Russia Irkutsk, Russia
Russia Kazan, Russia
Russia Khabarovsk, Russia
Russia Krasnodar, Russia
Russia Krasnoyarsk, Russia
Russia Moscow, Russia
Russia Murmansk, Russia
Russia Nalchik, Russia
Russia Nizhniy Novgorod, Russia
Russia Nizhny Novgorod, Russia
Russia Novosibirsk, Russia
Russia Omsk, Russia
Russia Orenburg, Russia
Russia Petrozavodsk, Russia
Russia Ryazan, Russia
Russia Saint-Petersburg, Russia
Russia Samara, Russia
Russia Saratov, Russia
Russia Smolensk, Russia
Russia Stavropol, Russia
Russia Tomsk, Russia
Russia Ufa, Russia
Russia Ulan-Ude, Russia
Russia Verkhnyaya Pyshma, Russia
Russia Vladimir, Russia
Russia Vladivostok, Russia
Russia Volgograd, Russia
Russia Voronezh, Russia
Russia Yekaterinburg, Russia